                               SEQUENCE LISTING

<110> MISSION BIO, INC.
 
<120> IMPROVED VARIANT CALLER USING SINGLE-CELL ANALYSIS

<130> MSB-022WO

<140> PCT/US2020/053971
<141> 2020-10-02

<150> 62/909,670
<151> 2019-10-02

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
agatcaccat cccta                                                        15


<210> 2
<211> 11
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
agatcaccac c                                                            11


<210> 3
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
agatgacgac cccta                                                        15


<210> 4
<211> 11
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gacgacaccg c                                                            11


<210> 5
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
agatcacgat cccgc                                                        15


<210> 6
<211> 13
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
agatcacgat ccc                                                          13


